- Home
- SPHR vs AVDL Comparison
SPHR vs AVDL Comparison
Compare SPHR & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHR
- AVDL
- Stock Information
- Founded
- SPHR 2020
- AVDL 2015
- Country
- SPHR United States
- AVDL Ireland
- Employees
- SPHR N/A
- AVDL N/A
- Industry
- SPHR Services-Misc. Amusement & Recreation
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- SPHR Consumer Discretionary
- AVDL Health Care
- Exchange
- SPHR Nasdaq
- AVDL Nasdaq
- Market Cap
- SPHR 1.5B
- AVDL 1.4B
- IPO Year
- SPHR N/A
- AVDL 1996
- Fundamental
- Price
- SPHR $42.46
- AVDL $15.24
- Analyst Decision
- SPHR Buy
- AVDL Strong Buy
- Analyst Count
- SPHR 9
- AVDL 7
- Target Price
- SPHR $51.00
- AVDL $19.86
- AVG Volume (30 Days)
- SPHR 779.4K
- AVDL 1.2M
- Earning Date
- SPHR 08-11-2025
- AVDL 08-07-2025
- Dividend Yield
- SPHR N/A
- AVDL N/A
- EPS Growth
- SPHR N/A
- AVDL N/A
- EPS
- SPHR N/A
- AVDL N/A
- Revenue
- SPHR $1,040,932,000.00
- AVDL $221,075,000.00
- Revenue This Year
- SPHR $9.19
- AVDL $63.77
- Revenue Next Year
- SPHR $6.15
- AVDL $29.91
- P/E Ratio
- SPHR N/A
- AVDL N/A
- Revenue Growth
- SPHR 1.37
- AVDL 132.35
- 52 Week Low
- SPHR $23.89
- AVDL $6.38
- 52 Week High
- SPHR $50.74
- AVDL $16.66
- Technical
- Relative Strength Index (RSI)
- SPHR 54.37
- AVDL 83.17
- Support Level
- SPHR $39.52
- AVDL $10.79
- Resistance Level
- SPHR $42.87
- AVDL $13.91
- Average True Range (ATR)
- SPHR 2.27
- AVDL 0.69
- MACD
- SPHR 0.08
- AVDL 0.20
- Stochastic Oscillator
- SPHR 62.09
- AVDL 92.80
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.